Indrayani Biotech Limited
BSE: INDRANIB
Prev Close
12.73
Open Price
12.99
Volume
60,449
Today Low / High
12.63 / 13.62
52 WK Low / High
12 / 37.93
Range
12 - 14
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 12.96, reflecting a change of 0.23 (1.80676%). The expected target range on the BSE is 12 - 14. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Indrayani Biotech Limited Graph
Indrayani Biotech Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Indrayani Biotech Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 12.96, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 12.96 | 13.09 | 11.78 - 14.40 |
| 13.22 | 10.58 - 15.86 | ||
| 13.35 | 9.34 - 17.35 | ||
| Bearish Scenario | 12.96 | 12.83 | 11.55 - 14.11 |
| 12.70 | 10.16 - 15.24 | ||
| 12.57 | 8.80 - 16.34 |
Overview of Indrayani Biotech Limited
ISIN
INE007C01021
Industry
Restaurants
Vol.Avg
58,327
Market Cap
579,677,099
Last Dividend
0
Official Website
IPO Date
2008-01-01
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 130.23 Cr | 82.77 Cr | 47.46 Cr | 0.3644 | 0.00 Cr | 0.00 Cr | 2.89 Cr | -6.11 Cr | -1.28 | 9.39 Cr | -0.0469 |
| 2024-03-31 | 166.23 Cr | 130.71 Cr | 35.52 Cr | 0.2137 | 0.00 Cr | 1.02 Cr | 19.86 Cr | 6.36 Cr | 1.63 | 24.66 Cr | 0.0383 |
| 2023-03-31 | 162.93 Cr | 102.21 Cr | 60.71 Cr | 0.3726 | 0.00 Cr | 2.89 Cr | 13.96 Cr | 11.93 Cr | 3.49 | 18.03 Cr | 0.0732 |
| 2022-03-31 | 61.57 Cr | 41.04 Cr | 20.53 Cr | 0.3334 | 0.00 Cr | 0.24 Cr | 6.12 Cr | 4.44 Cr | 1.30 | 6.88 Cr | 0.0721 |
| 2021-03-31 | 21.09 Cr | 15.77 Cr | 5.32 Cr | 0.2521 | 0.00 Cr | 0.40 Cr | -5.40 Cr | -11.21 Cr | -3.28 | -8.79 Cr | -0.5318 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.29 Cr | 268.17 Cr | 168.25 Cr | 72.5095 Cr | 137.07 Cr | 136.78 Cr | 41.34 Cr | 60.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 102.4837 Cr |
| 2024-03-31 | 0.58 Cr | 235.03 Cr | 158.76 Cr | 67.2119 Cr | 112.52 Cr | 111.94 Cr | 42.35 Cr | 59.38 Cr | 0.00 Cr | 0.00 Cr | -24.77 Cr | 87.0723 Cr |
| 2023-03-31 | 3.04 Cr | 155.96 Cr | 107.61 Cr | 55.0871 Cr | 70.19 Cr | 67.15 Cr | 12.21 Cr | 47.85 Cr | 0.77 Cr | -0.01 Cr | 0.22 Cr | 71.9097 Cr |
| 2022-03-31 | 1.50 Cr | 51.40 Cr | 26.83 Cr | 24.1634 Cr | 18.79 Cr | 17.29 Cr | 1.53 Cr | 25.94 Cr | 1.48 Cr | 0.01 Cr | 0.68 Cr | 19.4824 Cr |
| 2021-03-31 | 0.68 Cr | 40.05 Cr | 19.97 Cr | 19.7201 Cr | 15.54 Cr | 14.86 Cr | 1.09 Cr | 25.36 Cr | 0.91 Cr | 0.00 Cr | 0.01 Cr | 11.8068 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -6.7418 Cr | 24.7433 Cr | -18.2954 Cr | -8.1174 Cr | -0.2939 Cr | 0.2882 Cr | -1.3756 Cr | -6.1075 Cr | -2.3626 Cr | 0.0000 Cr | 1.0086 Cr |
| 2024-03-31 | -30.3541 Cr | -16.3390 Cr | 44.2385 Cr | -46.8414 Cr | -2.4546 Cr | 0.5821 Cr | -16.4873 Cr | 10.4225 Cr | 37.2261 Cr | 0.0000 Cr | -30.1366 Cr |
| 2023-03-31 | 16.1876 Cr | -47.3935 Cr | 32.7393 Cr | -27.2269 Cr | 1.5334 Cr | 3.0367 Cr | -43.4145 Cr | 11.9309 Cr | 22.5852 Cr | 0.0000 Cr | -10.6816 Cr |
| 2022-03-31 | 4.1110 Cr | -0.5581 Cr | -2.7296 Cr | 2.9035 Cr | 0.8233 Cr | 1.5033 Cr | -1.2075 Cr | 4.4395 Cr | -0.8188 Cr | 0.0000 Cr | -0.4431 Cr |
| 2021-03-31 | 0.2559 Cr | -0.7022 Cr | -0.2772 Cr | -0.4397 Cr | -0.7234 Cr | 0.6787 Cr | -0.6956 Cr | -11.2144 Cr | 1.2095 Cr | 0.0000 Cr | 3.9820 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 50.57 Cr | 40.18 Cr | 10.39 Cr | 0.2054 | -4.02 Cr | -7.40 Cr | -1.55 | -2.96 Cr | -0.1463 |
| 2024-12-31 | 17.32 Cr | 10.13 Cr | 7.18 Cr | 0.4148 | 1.46 Cr | 0.24 Cr | 0.05 | 2.92 Cr | 0.0138 |
| 2024-09-30 | 30.81 Cr | 14.87 Cr | 15.94 Cr | 0.5174 | 2.31 Cr | 1.22 Cr | 0.27 | 5.41 Cr | 0.0395 |
| 2024-06-30 | 31.53 Cr | 17.58 Cr | 13.94 Cr | 0.4423 | 8.23 Cr | 0.85 Cr | 0.19 | 4.02 Cr | 0.0270 |
| 2024-03-31 | 44.38 Cr | 29.43 Cr | 14.95 Cr | 0.3368 | 9.21 Cr | 4.73 Cr | 1.04 | 11.21 Cr | 0.1066 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.29 Cr | 26.21 Cr | 26.50 Cr | 67.25 Cr | 41.34 Cr | 177.94 Cr | 60.00 Cr | 268.17 Cr | 168.25 Cr |
| 2024-09-30 | 3.13 Cr | 44.44 Cr | 47.57 Cr | 46.65 Cr | 40.76 Cr | 159.96 Cr | 60.91 Cr | 251.68 Cr | 144.05 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 30.25 Cr | 0.00 Cr | 0.00 Cr | 30.25 Cr | 0.00 Cr | 0.00 Cr | -76.27 Cr |
| 2024-03-31 | 0.58 Cr | 29.67 Cr | 0.58 Cr | 64.07 Cr | 42.35 Cr | 144.98 Cr | 59.38 Cr | 235.03 Cr | 158.76 Cr |
| 2023-12-31 | -0.58 Cr | 1.16 Cr | 0.58 Cr | 0.00 Cr | 0.00 Cr | 0.58 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.85 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.12 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 1.08 Cr | 2.07 Cr | 0.00 Cr | 0.00 Cr | 2.07 Cr | 2.65 Cr | 0.58 Cr | 0.00 Cr | 2.07 Cr |
| 2023-09-30 | 5.54 Cr | 5.54 Cr | 0.00 Cr | 0.00 Cr | 5.54 Cr | 0.58 Cr | -4.96 Cr | 0.00 Cr | 5.54 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2015-09-24 | September 24, 15 | 3:25 |
Similar Stocks: Restaurants
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Jubilant FoodWorks Limited | JUBLFOOD | ₹639.75 | ₹422,135,838,750.00 | ₹712,647.00 |
| Devyani International Limited | DEVYANI | ₹158.86 | ₹195,705,988,400.00 | ₹5,965,123.00 |
| Westlife Foodworld Limited | WESTLIFE | ₹669.00 | ₹103,969,243,170.00 | ₹280,168.00 |
| Sapphire Foods India Limited | SAPPHIRE | ₹315.35 | ₹101,348,097,515.00 | ₹274,653.00 |
| Restaurant Brands Asia Limited | RBA | ₹79.14 | ₹46,073,883,480.00 | ₹318,802.00 |
Key Executives
Gender: male
Year Born: 1969
Gender: male
Year Born: 1966
Gender: male
Year Born:
Gender: male
Year Born: 1972
Gender: male
Year Born:
Gender: Not Specified
Year Born:
Gender: male
Year Born: 1961
FAQs about Indrayani Biotech Limited
The CEO is Kasiraman Sayee Sundar.
The current price is ₹12.73.
The range is ₹12-37.93.
The market capitalization is ₹57.97 crores.
The P/E ratio is -11.93.
The company operates in the Consumer Cyclical sector.
Overview of Indrayani Biotech Limited (ISIN: INE007C01021) is a leading Restaurants in India. With a market capitalization of ₹57.97 crores and an average daily volume of 58,327 shares, it operates in the Restaurants. The company last declared a dividend of ₹0.